DRDATSONS

Dr. Datson's Labs Limited has informed the Exchange that the Company to submit order copy of Bombay High Court dated February 18, 2015 (uploaded on website on March 27, 2015) and Minutes Copy of Official Liquidator dated April 30, 2015.

Dr. Datson's Labs Limited has informed the Exchange that the creditors of the Company in winding up petitions, vide its order dated February 18, 2015 (uploaded on website on March 27, 2015), appointed the official liquidator attached to the Bombay High Court as the provisional liquidator of Dr. Datsons Labs Limited (the Company ) and directed the provisional liquidator to forthwith take charge/possession of the Company s assets, properties, stock in trade, books of account, bank account and all other assets of the Company.

Dr. Datson's Labs Limited has informed the Exchange that Westminster Pharmaceuticals INC Based out of USA has sent us a communication showing interest in Company's contract manufacturing Generic Medicines in Private Label for Westminster Pharmaceuticals INC.

Dr. Datson's Labs Limited has informed the Exchange that the following changes in designation have taken place for the respective person:- 1. Mr. Rajendra Kamath, as a Vice Chairman and Managing Director of the company with effect from February 15, 2015. 2. Mr. Mahesh Vaidya, as Non Executive Chairman of the company with effect from February 15, 2015.

Dr. Datson's Labs Limited has informed the Exchange vide letter dated December 22, 2014 regarding "Message from Minister of Health & Family Welfare Government of India."

Dr. Datson's Labs Limited has informed the Exchange that the Company won The Coveted "Swiss International Quality Certificate".

Dr. Datson's Labs Limited has informed the Exchange regarding the Change in Corporate/ Admin Office of the Company:- From Plot No 34, Postal Colony, Chembur, Mumbai 400071, India To Dr. Datsons House, Plot No W-91(D) MIDC Taloja 410208, Dist -Raigad, State- Maharashtra India w.e.f. August 01, 2014.

Dr. Datson's Labs Limited has informed the Exchange that the Company received International Star Award for Quality to be conferred upon the company at the ISAQ Convention.

Dr. Datson's Labs Limited has informed the Exchange that in accordance with the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992, the trading window of the Company will remain closed from May 19, 2014 to May 31, 2014 for the purpose of consider and approve the Audited Financial Results for the financial year ended March 31, 2014.

Dr. Datson's Labs Limited has informed the Exchange that Mires B.V ( Proposed Acquirer ) completed the valuation of the two plants of the company situated at Mahad and Pune. The Total Fair Valuation of the Company as stood at Rs 350 Crores out which valuation of the fixed assets of the company stood at Rs. 270 Crores. The Detailed term sheet for process of proposed Acquisition will be received by the company shortly.The Company undertakes to take all necessary steps for the Benefit of the stakeholders of the company.

Dr. Datson's Labs Limited has informed the Exchange that "the company has received Letter of interest between Mires B.V a European based Pharma Company ( Proposed Acquirer ) and Dr. Datsons Labs Limited ( Target Company ) Summarize their mutual interest in the Acquirer buying the Target Company. The Acquirer Proposed the Enterprise Valuation of the target company is decided post Due Diligence. The Acquirer proposed to buy Majority stake in the target company and The Company undertakes to take all necessary steps for the Benefit of the stakeholders of the company".

Aanjaneya Lifecare Ltd has informed the Exchange that: 1. Aanjaneya Lifecare Limited (ALL) became holding Company of "FAIR SUCCESS (H.K) LIMITED" a Company incorporated in the Hong Kong, by way of acquiring 100% ordinary share capital of the said Hong Kong based Company. 2. Aanjaneya Lifecare Limited (ALL) have incorporated Wholly owned Subsidiary named "Dr. Datsons Labs Limited" a Company incorporated in United Kingdom, by way of subscribing 100% ordinary share capital of the said Subsidiary Company.

Aanjaneya Lifecare Limited has informed the Exchange regarding the following : "Aanjaneya Lifecare Limited [ALL] have incorporated Wholly owned Subsidiary named "AANJ Pharmalabs Limited FZE" in Dubai AirPort Free Zone a Company incorporated in UAE, by way of subscribing 100% ordinary share capital of the said Subsidiary Company".

Aanjaneya Lifecare Limited has informed the Exchange that "with reference to the press release bearing no F.NO.11(1)/2012-FIPB, Government of India, Ministry of Finance, Department of economic Affairs (FIPB Unit) Dated January 11, 2013 that the proposal of Foreign Currency Convertible Bonds Amounting to Rs. 405.00 Crore ( Four Hundred Five Crore only ) of our company have been recommended by FIPB and approved by Ministry of finance government of India".

Aanjaneya Lifecare Limited has informed the Exchange that the company begins the Fiscal on a Strong Note, bags coveted "Asia's Emerging Pharmaceutical Company on Innovations Award 2013" at Assocham's 10th Knowledge Millennium Summit. The Department of Science & Technology, Ministry of Science & Technology Government of India. Organised by The Associated Chambers of Commerce and Industry of India (ASSOCHAM).

Aanjaneya Lifecare Limited has informed the Exchange vide letter dated September 24, 2012, regarding "Prestigious "BSE AWARD for BEST RETURN TO INVESTORS 2012".

Aanjaneya Lifecare Limited has informed the Exchange that the company won the "Europe Awards Best Practices in Corporate Governance 2012" by European Society of Quality Research at Amsterdam Holland on April 15, 2012.

Aanjaneya Lifecare Limited has informed the Exchange that the company received the following awards on April 06, 2012 : (1) The IMC Ramkrishna Bajaj National Quality Awards 2012 "Certificate of Merit" in Small Business Catagory at NCAP in Mumbai; (2) Company awarded the "Best Corporate Governance, India, 2012" at the 3rd Annual India Business Ship Conclave & India Business Awards 2012; (3) Dr. Kannan Vishwanath Received the "Business Leader of Year 2012" at the 3rd Annual India Business Ship Conclave & India Business Awards 2012.

Aanjaneya Lifecare Limited has informed the Exchange that Aanjaneya Lifecare Limited [ALL] became holding Company of EROS PHARMACHEM PTE. LIMITED, a Company incorporated in the Republic of Singapore, by way of acquiring 90% ordinary share capital of the said Singapore based Company.

Aanjaneya Lifecare Limited has informed the Exchange that Mr. Mani Iyer has resigned from the post of "Chief Financial Officer" of the Company and Mr. Lalit Shukla has been appointed as "President - Accounts & Finance" of the Company.

Aanjaneya Lifecare Limited has informed the Exchange that the Company "Aanjaneya Lifecare Limited" has featured in the Top 100 of India's Best Companies to Work for 2011 by "The Great Place to Work - Institute India"